VenatoRx Pharmaceuticals' Grant - II Round

VenatoRx Pharmaceuticals raised a round of funding on January 04, 2018. Investors include U.S. Department of Defense.

VenatoRx Pharmaceuticals is a disease-focused pharmaceutical company dedicated to the discovery and development of novel anti-infective agents. The company's goal is to identify and progress into clin…

Articles about VenatoRx Pharmaceuticals' Grant - II Round: